A polygenic-informed approach to a predictive EEG signature empowers stratified antidepressant treatment
Guardado en:
Autores principales: | Hannah Meijs, Bochao Lin, Guido van Wingen, Evian Gordon, Damiaan Denys, Bieke De Wilde, Jan Van Hecke, Peter Niemegeers, Kristel van Eijk, Jurjen Luykx |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0838a0e7f5b145c1b04cdd4e32dd312b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Exploring the role of Polygenetic risk scores for MDD treatment outcome in sex and different antidepressants groups
por: Bochao Lin, et al.
Publicado: (2021) -
Brainmarker-I: a transdiagnostic EEG biomarker predicting remission to various depression and ADHD treatments
por: Helena Voetterl, et al.
Publicado: (2021) -
Investigating EEG biomarker specificity to combined rTMS with psychotherapy: Psychotherapy, rTMS or sham? A blinded prediction study
por: Amourie Prentice, et al.
Publicado: (2021) -
Heartbeat evoked potential in major depressive disorder: Differential treatment prediction for antidepressant medication and rTMS
por: Lauren Zwienenberg, et al.
Publicado: (2021) -
Genetic risk for schizophrenia is associated with altered visually-induced gamma band activity: evidence from a population sample stratified polygenic risk
por: S. I. Dimitriadis, et al.
Publicado: (2021)